Decade-long use of the antimicrobial peptide combination tyrothricin does not pose a major risk of acquired resistance with gram-positive bacteria and Candida spp

Publisher: Govi-Verlag

ISSN: 0031-7144

Source: Die Pharmazie - An International Journal of Pharmaceutical Sciences, Vol.69, Iss.11, 2014-11, pp. : 838-841

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract